Rheumatoid arthritis (RA) is a systemic autoimmune disease that predominantly affects the
joints. The prevalence of RA varies globally, with generally a higher prevalence in …

New treatment strategies have substantially changed the course of rheumatoid arthritis.
Many patients can achieve remission if the disease is recognised early and is treated …

Objectives To compare mortality risks in patients with rheumatoid arthritis-associated
interstitial lung disease (RA-ILD) and patients with RA without ILD. Design Matched cohort …

Gout is a common hyperuricaemic metabolic condition that leads to painful inflammatory
arthritis and a high comorbidity burden, especially cardiometabolic-renal (CMR) conditions …

Dietary recommendations for the management of hyperuricemia and gout should be
approached holistically, taking into consideration its associated cardiometabolic …

Objective Patients with SLE have increased morbidity and premature mortality. Whether this
mortality gap has improved in recent years, as in RA, is unknown. Methods We conducted a …

Interstitial lung disease (ILD) is a serious complication of rheumatoid arthritis (RA)
contributing to significantly increased morbidity and mortality. Other respiratory …

Background The unmet need in systemic lupus erythematosus (SLE) with the current
standard of care is widely recognised, but few studies have quantified this. The recent …

Objectives To examine all-cause and cardiovascular disease (CVD) mortality in consecutive
cohorts of patients with incident RA, compared with population comparators. Methods The …

Objective To determine whether patients with rheumatoid arthritis (RA) are at higher risks for
SARS–CoV‐2 infection and its severe outcomes before and after COVID‐19 vaccination …